Envestnet Asset Management Inc. increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 180.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,820 shares of the insurance provider's stock after purchasing an additional 24,964 shares during the quarter. Envestnet Asset Management Inc.'s holdings in Humana were worth $15,420,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Johnson Financial Group Inc. acquired a new position in shares of Humana during the 2nd quarter worth approximately $26,000. Trust Co. of Vermont bought a new position in shares of Humana in the second quarter valued at $28,000. Reflection Asset Management bought a new position in shares of Humana in the fourth quarter valued at $29,000. Bogart Wealth LLC increased its holdings in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock worth $29,000 after buying an additional 48 shares during the last quarter. Finally, MidFirst Bank acquired a new position in Humana during the second quarter worth $35,000. Institutional investors own 92.38% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have commented on HUM shares. Robert W. Baird set a $390.00 price target on shares of Humana in a research note on Thursday, July 30th. Oppenheimer restated an "outperform" rating and set a $405.00 price objective on shares of Humana in a research note on Thursday, July 30th. Weiss Ratings raised shares of Humana from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, August 14th. Royal Bank Of Canada raised their target price on shares of Humana from $246.00 to $415.00 and gave the company a "sector perform" rating in a research note on Thursday, July 9th. Finally, Wolfe Research reiterated an "outperform" rating and set a $450.00 price target on shares of Humana in a report on Monday, August 24th. Fifteen analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $408.61.
Get Our Latest Analysis on Humana
Humana Stock Down 1.1%
Humana stock opened at $382.71 on Thursday. The company's 50-day moving average price is $385.70 and its two-hundred day moving average price is $323.37. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a market cap of $45.96 billion, a P/E ratio of 36.21, a P/E/G ratio of 2.39 and a beta of 0.74. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88.
Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business's revenue was up 26.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.27 earnings per share. As a group, analysts expect that Humana Inc. will post 9 EPS for the current year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be paid a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana's payout ratio is 33.49%.
Humana Profile
(
Free Report)
Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.
Humana's insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.